Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.

Ashton JM, Balys M, Neering SJ, Hassane DC, Cowley G, Root DE, Miller PG, Ebert BL, McMurray HR, Land H, Jordan CT.

Cell Stem Cell. 2012 Sep 7;11(3):359-72. doi: 10.1016/j.stem.2012.05.024. Epub 2012 Aug 2.

2.

Survival regulation of leukemia stem cells.

Hu Y, Li S.

Cell Mol Life Sci. 2016 Mar;73(5):1039-50. doi: 10.1007/s00018-015-2108-7. Epub 2015 Dec 19. Review.

PMID:
26686687
3.

Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

Passegué E, Jamieson CH, Ailles LE, Weissman IL.

Proc Natl Acad Sci U S A. 2003 Sep 30;100 Suppl 1:11842-9. Epub 2003 Sep 22. Review.

5.

Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.

Pelosi E, Castelli G, Testa U.

Blood Cells Mol Dis. 2015 Dec;55(4):336-46. doi: 10.1016/j.bcmd.2015.07.015. Epub 2015 Jul 26. Review.

PMID:
26460257
6.

Considerations for targeting malignant stem cells in leukemia.

Guzman ML, Jordan CT.

Cancer Control. 2004 Mar-Apr;11(2):97-104. Review.

7.

Leukemic stem cells: where do they come from?

Passegué E, Weisman IL.

Stem Cell Rev. 2005;1(3):181-8. Review.

PMID:
17142854
8.

Selective elimination of leukemia stem cells: hitting a moving target.

Crews LA, Jamieson CH.

Cancer Lett. 2013 Sep 10;338(1):15-22. doi: 10.1016/j.canlet.2012.08.006. Epub 2012 Aug 17. Review.

PMID:
22906415
9.

Right on target: eradicating leukemic stem cells.

Krause DS, Van Etten RA.

Trends Mol Med. 2007 Nov;13(11):470-81. Epub 2007 Nov 5. Review.

10.

Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Misaghian N, Ligresti G, Steelman LS, Bertrand FE, Bäsecke J, Libra M, Nicoletti F, Stivala F, Milella M, Tafuri A, Cervello M, Martelli AM, McCubrey JA.

Leukemia. 2009 Jan;23(1):25-42. doi: 10.1038/leu.2008.246. Epub 2008 Sep 18. Review.

11.

Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology.

ten Cate B, de Bruyn M, Wei Y, Bremer E, Helfrich W.

Curr Drug Targets. 2010 Jan;11(1):95-110. Review.

PMID:
20017722
12.

Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.

Kikushige Y, Miyamoto T.

Oncology. 2015;89 Suppl 1:28-32. doi: 10.1159/000431062. Epub 2015 Nov 10. Review.

PMID:
26551150
13.

Leukemia stem cells.

Luo L, Han ZC.

Int J Hematol. 2006 Aug;84(2):123-7. Review.

PMID:
16926133
14.

Chronic myeloid leukemia stem cells.

Kavalerchik E, Goff D, Jamieson CH.

J Clin Oncol. 2008 Jun 10;26(17):2911-5. doi: 10.1200/JCO.2008.17.5745. Review.

PMID:
18539972
15.

Role of microRNAs in leukemia stem cells.

Huang J, Mo YY.

Front Biosci (Schol Ed). 2012 Jan 1;4:799-809. Review.

PMID:
22202091
16.

Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?

García-Ramírez I, Martín-Lorenzo A, González-Herrero I, Rodriguez-Hernández G, Vicente-Dueñas C, Sánchez-García I.

Int J Mol Sci. 2016 Jun 6;17(6). pii: E889. doi: 10.3390/ijms17060889. Review.

17.

Mechanisms controlling pathogenesis and survival of leukemic stem cells.

Jordan CT, Guzman ML.

Oncogene. 2004 Sep 20;23(43):7178-87. Review.

PMID:
15378078
18.

Leukemia stem cells and microenvironment: biology and therapeutic targeting.

Konopleva MY, Jordan CT.

J Clin Oncol. 2011 Feb 10;29(5):591-9. doi: 10.1200/JCO.2010.31.0904. Epub 2011 Jan 10. Review.

19.

Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells.

Li L, Bhatia R.

Curr Opin Hematol. 2015 Jul;22(4):324-9. doi: 10.1097/MOH.0000000000000152. Review.

20.

Eradication of leukemia stem cells as a new goal of therapy in leukemia.

Ravandi F, Estrov Z.

Clin Cancer Res. 2006 Jan 15;12(2):340-4. Review.

Supplemental Content

Support Center